Search

Author/Creator Knorr, David

2. CTIM-23. DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS). (14th November 2022)

Authors:
Desjardins, Annick; Chandramohan, Vidya; Landi, Daniel; Peters, Katherine B; Johnson, Margaret; Khasraw, Mustafa; Low, Justin; Threatt, Stevie; Bullock, Chevelle; II, James E Herndon; Lipp, Eric S; Sampson, John; Friedman, Allan; Friedman, Henry S; Ashley, David; Knorr, David; Ravetch, Jeffrey; B...
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search